A survey of laboratory biosafety and protective measures in blood transfusion departments during the COVID‐19 pandemic

Background and objectives Thousands of healthcare workers (HCWs) have been infected with 2019 novel coronavirus pneumonia (COVID‐19) during the COVID‐19 pandemic. Laboratory personnel in blood transfusion departments may be infected with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) if laboratory biosafety protection is insufficient. Therefore, we investigated the current situation of laboratory biosafety protection in blood transfusion departments to determine how to improve the safety of laboratory processes. Materials and methods An online survey was conducted in blood transfusion departments from 1st to 6th May 2020 in China. A total of 653 individuals completed the questionnaire. The questionnaire was designed with reference to COVID‐19 laboratory biosafety summarized in Annex II. All responses were summarized using only descriptive statistics and expressed as frequencies and ratios [n (%)]. Results Most participants were concerned about COVID‐19. Some participants had inadequate knowledge of COVID‐19. Two participants stated that there were laboratory personnel infected with SARS‐CoV‐2 in their departments. A total of 31 (4.7%) participants did not receive any safety and security training. In terms of laboratory biosafety protection practices, the major challenges were suboptimal laboratory safety practices and insufficient laboratory conditions. Conclusion The major deficiencies were insufficient security and safety training, and a lack of personal protective equipment, automatic cap removal centrifuges and biosafety cabinets. Consequently, we should enhance the security and safety training of laboratory personnel to improve their laboratory biosafety protection practices and ensure that laboratory conditions are sufficient to improve the safety of laboratory processes.